Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Average Recommendation of "Hold" by Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) has been given a consensus rating of "Hold" by the six brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $5.25.

Several brokerages have commented on AVAH. Barclays began coverage on shares of Aveanna Healthcare in a research note on Wednesday, July 2nd. They issued an "equal weight" rating and a $5.50 price target on the stock. Jefferies Financial Group upgraded shares of Aveanna Healthcare from a "hold" rating to a "buy" rating and decreased their price target for the stock from $6.25 to $6.00 in a research note on Monday, July 21st. Wall Street Zen cut shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 27th. Truist Financial decreased their target price on shares of Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Finally, UBS Group upped their target price on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th.

Aveanna Healthcare Stock Up 0.5%

Shares of AVAH stock opened at $3.96 on Friday. The stock has a market cap of $772.56 million, a P/E ratio of 198.00 and a beta of 1.98. Aveanna Healthcare has a 52 week low of $2.61 and a 52 week high of $6.19. The company's fifty day simple moving average is $4.83 and its two-hundred day simple moving average is $4.82.

Insider Buying and Selling

In related news, CAO Deborah Stewart sold 15,457 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $5.56, for a total value of $85,940.92. Following the sale, the chief accounting officer directly owned 285,396 shares of the company's stock, valued at $1,586,801.76. This represents a 5.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 750,000 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the completion of the sale, the insider directly owned 28,890,756 shares in the company, valued at $150,231,931.20. This trade represents a 2.53% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,115,345 shares of company stock worth $37,838,057 over the last three months. 7.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aveanna Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. Summit Partners L P bought a new position in Aveanna Healthcare in the 2nd quarter worth about $50,477,000. Diversified Trust Co bought a new position in Aveanna Healthcare in the 2nd quarter worth about $57,000. Rhumbline Advisers grew its stake in Aveanna Healthcare by 4.0% in the 1st quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock worth $410,000 after acquiring an additional 2,918 shares in the last quarter. Strs Ohio bought a new position in Aveanna Healthcare in the 1st quarter worth about $218,000. Finally, Acadian Asset Management LLC grew its stake in Aveanna Healthcare by 9.2% in the 1st quarter. Acadian Asset Management LLC now owns 352,215 shares of the company's stock worth $1,902,000 after acquiring an additional 29,811 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.